Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer Aspirin, Eflornithine, Laboratory Biomarker Analysis, Placebo, Telephone-Based Intervention NCT00983580 National Cancer Institute (NCI) Active, not recruiting
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules Aspirin, Laboratory Biomarker Analysis, Placebo NCT02169271 National Cancer Institute (NCI) Active, not recruiting
ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing... Laboratory Biomarker Analysis, Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet, Pharmacological Study, Placebo NCT02917629 National Cancer Institute (NCI) Recruiting
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT03063619 M.D. Anderson Cancer Center Recruiting
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery NCT02598557 National Cancer Institute (NCI) Recruiting
Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers Aspirin, Laboratory Biomarker Analysis, Placebo, Zileuton NCT02348203 National Cancer Institute (NCI) Recruiting
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma Aspirin, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT02965703 National Cancer Institute (NCI) Recruiting
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful... Aspirin, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT02521285 National Cancer Institute (NCI) Active, not recruiting
Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission Berberine Chloride, Laboratory Biomarker Analysis, Placebo NCT02365480 National Cancer Institute (NCI) Active, not recruiting
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... Curcumin, Laboratory Biomarker Analysis, Placebo, Quality-of-Life Assessment NCT02782949 National Cancer Institute (NCI) Recruiting

Pages